125 results
8-K
EX-3.2
KRTX
Karuna Therapeutics Inc
18 Mar 24
Completion of Acquisition or Disposition of Assets
9:04am
directs, by independent legal counsel in a written opinion, or (d) by the stockholders of the corporation.
Section 5.5 Advancement of Expenses … of directors or any committee thereof, independent legal counsel, or stockholders) to make a determination concerning the permissibility
DEFM14A
n38cd64cij
5 Feb 24
Proxy related to merger
4:12pm
PREM14A
tz1hyqfu
22 Jan 24
Preliminary proxy related to merger
6:05am
DEFA14A
0c7mrxmsxsws9zpklsbt
22 Dec 23
Additional proxy soliciting materials
5:20pm
DEFA14A
21k c564xg
22 Dec 23
Additional proxy soliciting materials
5:20pm
8-K
EX-2.1
7pg7 6bqg1c6uh
22 Dec 23
Entry into a Material Definitive Agreement
5:07pm
DFAN14A
z7in1jd7ba dp4z
22 Dec 23
Additional proxy materials by non-management
4:36pm
8-K
EX-99.1
7mt0qbvd7
3 Aug 23
Karuna Therapeutics Reports Second Quarter 2023 Financial Results and Provides General Business Updates
6:37am
S-3ASR
EX-5.2
pkcjgxsxes9r6lf8tx3p
21 Jun 23
Automatic shelf registration
5:15pm
S-3ASR
EX-5.1
sclt9
21 Jun 23
Automatic shelf registration
5:15pm
S-3ASR
ezv796a07ns5u2bnh
21 Jun 23
Automatic shelf registration
5:15pm
S-3ASR
EX-1.2
mgwkluozfif
21 Jun 23
Automatic shelf registration
5:15pm
S-3ASR
EX-4.3
yas19nq44zzut9d2lk
21 Jun 23
Automatic shelf registration
5:15pm